Decision Diagnostics (Decision Diagnostics) Additional Paid-In Capital : $79.96 Mil(As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Decision Diagnostics Additional Paid-In Capital?

Decision Diagnostics's quarterly additional paid-in capital increased from Mar. 2021 ($79.95 Mil) to Jun. 2021 ($79.95 Mil) and increased from Jun. 2021 ($79.95 Mil) to Sep. 2021 ($79.96 Mil).

Decision Diagnostics's annual additional paid-in capital increased from Dec. 2018 ($47.96 Mil) to Dec. 2019 ($50.06 Mil) and increased from Dec. 2019 ($50.06 Mil) to Dec. 2020 ($79.93 Mil).

Decision Diagnostics Additional Paid-In Capital Historical Data

The historical data trend for Decision Diagnostics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decision Diagnostics Additional Paid-In Capital Chart

Decision Diagnostics Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec17

Dec18

Dec19

Dec20

Additional Paid-In Capital

Get a 7-Day Free Trial

24.05

46.29

47.96

50.06

79.93

Decision Diagnostics Quarterly Data
	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Additional Paid-In Capital	Get a 7-Day Free Trial															72.79	79.93	79.95	79.95	79.96

Decision Diagnostics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Decision Diagnostics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Decision Diagnostics (Decision Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361

Website

http://www.decisiondiagnostics.co

Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.

Executives

Keith Berman	director, officer: Secretary	2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich	director	765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox	director, officer: President